Search Results - "Turk, Amy N."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2
  3. 3

    Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis by Brosius, Stephanie N., Turk, Amy N., Byer, Stephanie J., Brossier, Nicole M., Kohli, Latika, Whitmire, Amber, Mikhail, Fady M., Roth, Kevin A., Carroll, Steven L.

    Published in Acta neuropathologica (01-04-2014)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are Schwann cell-derived malignancies that arise from plexiform neurofibromas in patients with mutation of…”
    Get full text
    Journal Article
  4. 4

    Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner by Byer, Stephanie J., Eckert, Jenell M., Brossier, Nicole M., Clodfelder-Miller, Buffie J., Turk, Amy N., Carroll, Andrew J., Kappes, John C., Zinn, Kurt R., Prasain, Jeevan K., Carroll, Steven L.

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2011)
    “…Few therapeutic options are available for malignant peripheral nerve sheath tumors (MPNSTs), the most common malignancy associated with neurofibromatosis type…”
    Get full text
    Journal Article
  5. 5

    Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis by Jing, Gu, Yuan, Kaiyu, Turk, Amy N, Jhala, Nirag C, Arnoletti, Juan P, Zhang, Kui, McDonald, Jay M, Chen, Yabing

    Published in Laboratory investigation (01-06-2011)
    “…Cholangiocarcinoma is a highly malignant tumor with limited therapeutic options. We have previously reported that tamoxifen (TMX) induces apoptosis of…”
    Get full text
    Journal Article
  6. 6

    Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents by Turk, Amy N, Byer, Stephanie J, Zinn, Kurt R, Carroll, Steven L

    Published in Journal of visualized experiments (07-03-2011)
    “…Although in vitro screens are essential for the initial identification of candidate therapeutic agents, a rigorous assessment of the drug's ability to inhibit…”
    Get full text
    Journal Article
  7. 7

    Abstract 4089: Calmodulin antagonists inhibit cholangiocarcinoma tumorigenesis independent of gemcitabine by the activating of caspase 2 by Jing, Gu, Yuan, Kaiyu, Turk, Amy N., McDonald, Jay M., Chen, Yabing

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Cholangiocarcinoma is a highly malignant tumor with limited therapeutic options. Gemcitabine (GMT) is currently used as a first line chemotherapeutical reagent…”
    Get full text
    Journal Article
  8. 8

    Abstract 126: Gemcitabine enhances therapeutic effect of tamoxifen on cholangiocarcinoma by Jing, Gu, Turk, Amy N., Sun, Yong, Pawar, Pritish, Chen, Yabing, McDonald, Jay M.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Gemcitabine enhances therapeutic effect of tamoxifen on cholangiocarcinoma Gu Jing, Amy N Turk, Yong Sun, Pritish Pawar, Yabing Chen, Jay M McDonald…”
    Get full text
    Journal Article
  9. 9